Treatment of sex offenders with medroxyprogesterone acetate
about
Pharmacological interventions for those who have sexually offended or are at risk of offendingThe use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia.The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias.Use of propranolol for hypersexual behavior in an adolescent with autism.Leuprolide acetate suppresses pedophilic urges and arousability.Hypersexual disorder: a proposed diagnosis for DSM-V.Relevance of non-human animal studies to the understanding of human sexuality.The effects of cyproterone acetate on sleeping and waking penile erections in pedophiles: possible implications for treatment.Sexuality in Huntington's disease.Pharmacological management of inappropriate sexual behaviours: a review of its evidence, rationale and scope in relation to men with intellectual disabilities.Elderly Sexual Offenders.Psychopharmacological therapy of deviant sexual behavior.The long-term use of cyproterone acetate in pedophilia: a case study.Acute neuroendocrine response to sexual stimulation in sexual offenders.Leuprolide acetate for exhibitionism in Huntington's disease.A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles.Sex offending and sexual appetite: the clinical and theoretical relevance of hypersexual desire.The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist.
P2860
Q24188082-85EABD76-3B89-440E-835A-F63CBD483777Q24541514-31BD2718-0923-4319-97E3-2F3381609AF7Q32061349-5EC2BA2C-E33C-47C4-8A25-D5D8FCA5901AQ34114658-6E2C5549-ECEF-46D7-AFFF-1728D34204A3Q34426519-AE3C747E-A301-4A2C-8EDC-EE45E3A0442FQ34477600-8C4DA08F-16B0-4A3D-AE22-9D65AF31B683Q35014460-B5FBB22D-0429-44A6-A086-FB218DBDAD8EQ35197722-3BB7F478-BCD4-4C21-BE82-E8FC72DD1A32Q35868356-CBC55F84-F979-43BD-AB5A-4A3358C8E9F0Q37106211-BE2FCE77-2AED-4AEA-A97B-C9899ED41848Q37192628-5B216005-D399-46C2-914F-E5CDE91A8B9EQ38906047-69F1E878-4705-4E01-9F1C-BC3AC9263F63Q39485438-6EFE9818-967E-4387-AF24-E1F92EC11202Q42095725-C2290C14-AB22-4030-9B6D-695AFEC8DBE5Q44459618-2AA966C0-FFC8-4751-B54C-3478AB9573EDQ45289513-F24E1E1E-5FF5-4DB2-909B-B39E391CA8AFQ46283300-9E521050-B00D-411E-B98C-C026723C0BB7Q47629409-686A431D-CFC9-4DCD-9BEE-A0B1D379A0B7Q54260851-69A6C363-B599-4E5D-A650-A53C8D4CD5D1
P2860
Treatment of sex offenders with medroxyprogesterone acetate
description
im Mai 1981 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1981
@uk
name
Treatment of sex offenders with medroxyprogesterone acetate
@en
Treatment of sex offenders with medroxyprogesterone acetate
@nl
type
label
Treatment of sex offenders with medroxyprogesterone acetate
@en
Treatment of sex offenders with medroxyprogesterone acetate
@nl
prefLabel
Treatment of sex offenders with medroxyprogesterone acetate
@en
Treatment of sex offenders with medroxyprogesterone acetate
@nl
P356
P1476
Treatment of sex offenders with medroxyprogesterone acetate
@en
P304
P356
10.1176/AJP.138.5.644
P407
P577
1981-05-01T00:00:00Z